We identified genes encoding proteins regulating signaling downstream of ALK that were modulated by both ALK inhibitors, with the most interesting hit being NF1. In parallel, we generated resistant cell populations in an ALK-mutated neuroblastoma cell line through constant lorlatinib or ceritinib exposure. This evidence concerns the gene ALK and neuroblastoma.